Industry

STAFFORD, Texas–(BUSINESS WIRE)–Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced the following: We believe that the Company is well capitalized with cash balance reported on the Company’s Form 10-Q for … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended July 2, 2022. Second Quarter 2022 Highlights Second quarter revenue was $10.97 billion. Second quarter GAAP diluted earnings per share (EPS) was $4.22. Second quarter adjusted EPS was $5.51. Delivered very … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–#finance–Genoa Ventures, the pioneering venture firm investing in the convergence of biology and technology, today announced the successful close of $84 million for Genoa Ventures Fund II. The new fund will continue Genoa’s investing focus on startups innovating in markets as diverse as research tools, diagnostics, Agri/Food Bio, and industrial bio. Genoa’s first … [Read more…]

COVID-19 drug remdesivir slips to No. 2 spot in total Vizient member spend IRVING, Texas–(BUSINESS WIRE)–#teamvizient—Vizient, Inc. released its Summer 2022 Pharmacy Market Outlook forecasting a 3.26% overall drug price inflation rate for the calendar year beginning Jan. 1, 2023. The rate reflects a continued trend toward moderation of the overall increase in drug prices, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Cardiac Monitoring Devices Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. This research service provides an overview of the global cardiac monitoring devices market. The geographical scope of this global study is North America (NA), Europe, and Asia-Pacific (APAC). It offers a detailed analysis of market sizing, trends, competitive landscape, future … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–HealthTrust Performance GroupSM, a leading improvement catalyst for healthcare, hosted the 24th annual HealthTrust University (HTU) conference to recognize, educate and inspire leading healthcare systems across the country around supply chain excellence, sustainability and innovation benefiting patients and communities. With the theme, “Boldly Forward, The Future of a World Disrupted,” the live event … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Sickle Cell Anemia Testing & Screening Market Research Report by Technology, Age Group, Sector, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Sickle Cell Anemia Testing & Screening Market size was estimated at USD 805.21 million in 2021, USD 911.81 million … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “An Introduction to the Medical Device Regulation Training Course” conference has been added to ResearchAndMarkets.com’s offering. This seminar provides an invaluable overview of the European Medical Device Regulation (MDR). The interactive programme will explain the new legislation and which products are covered, the involvement of Notified Bodies and how to choose one and … [Read more…]

Q1 FY2022 Results Demonstrate a Strong Start to the Year with Core Revenue Growth at Constant Exchange Rate (CER) of +8.3% (Reported Revenue +2.4%) Growth and Launch Products Delivering Revenue Growth of +26% at CER Core Operating Profit Growth of +17% at CER, Core Operating Profit Margin 32.8% Reported Revenue and Operating Profit Growth Affected … [Read more…]

The last volunteer was enrolled in the REVERSE-IT study; recruitment of the 600 participants in this international, multicenter, randomized, placebo-controlled clinical study is complete. This Phase II/III study is evaluating the efficacy of TOTUM•63, a plant-based active substance, in a population with impaired glucose metabolism, from prediabetes to untreated type 2 diabetes (early stage). The … [Read more…]